Platelet-Rich Plasma (PRP) in Breast Cancer Patients: An Application Analysis of 163 Sentinel Lymph Node Biopsies

Table 2

Documentation on tumor size and grading could not be procured for all cases due to the retrospective nature of this work. No patients were excluded.

	ACP/PRP		Control (no ACP/PRP)		value
	No.	%	No.	%
Patients	82		81
Metastatis in SNL	10	12.2	14	17.3	0.3594
Tumor size
Tis	3	3.7	4	4.9
T1	57	69.5	41	50.6
T2	21	25.6	30	37.0
T3	0		3	3.7	0.607
Grading
G1	15	18.3	17	21.0
G2	49	59.8	46	56.8
G3	11	13.4	18	22.2	0.7943
Hormone receptor status
Positive	72	87.8	72	88.9
Negative	10	12.2	9	11.1	0.0037
HER2/neu
Positive	54	65.9	35	43.2
Negative	28	34.1	46	56.8	0.0037

All percentage data was calculated excluding the missing data (tumor size: ACP , no ACP ; grading: ACP , no ACP ).